IP Library Granted Patent US 11,078,477
Granted Patent B2
US 11,078,477 · App. 16/663,212 · Granted Aug 3, 2021

Automated isolation and chemical reaction(s) of nucleic acids

Inventors: Xiaoliang Han (San Francisco, CA); James Jianming Wang (Newark, CA); Tong Lu (Newark, CA)
Assignee: BIOCHAIN INSTITUTE, INC.
C12N15/1013B01L3/50851C12Q1/6806G01N1/10B01L2300/0858G01N35/0098G01N2035/00564
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,078,477
App. No.
16/663,212
Granted
Aug 3, 2021
Kind
B2
Abstract

The present teachings relate to methods, kits and devices for performing automated sequential nucleic acid isolation and conversion/purification in a single closed system. In various embodiments, the present teaching enable a user to (i) load a device with test samples, reagents and consumables; (ii) select or program the device for the desired nucleic acid isolation and subsequent chemical treatment and/or conversion reaction(s) without further user intervention; and recovering the isolated and treated and/or converted nucleic acid at the conclusion of the program once the device is activated.

Claims (21)

1. A method for performing sequential nucleic acid isolation and conversion/purification reaction(s) in a closed automated device which includes:

(A) a plurality of reaction reservoirs;

(B) a heating unit configured to heat the plurality of reaction reservoirs;

(C) a magnet configured to be elevated and lowered relative to the reaction reservoirs;

the method comprising:

a. contacting the nucleic acid-containing sample with an extraction reagent in a first reservoir of the plurality of the reaction chambers to thereby extract the nucleic acid from the sample;

b. binding the extracted nucleic acid with a first plurality of magnetic beads in the first reservoir;

c. while holding the magnetic beads down by elevating the magnet relative to the first plurality of magnetic beads, removing liquid supernatant formed in the first reservoir;

d. eluting the bound extracted nucleic acid from the first plurality of magnetic beads using a first elution buffer while subjecting the first reservoir to a first elevated temperature by the heating unit for a first predetermined duration of time to thereby obtain an isolated nucleic acid eluent;

e. while holding the magnetic beads down by elevating the magnet relative to the first plurality of magnetic beads, transferring the isolated nucleic acid eluent to a second reservoir of the plurality of reaction reservoirs, the second reaction reservoir containing a conversion reagent;

f. reacting said isolated nucleic acid with the conversion reagent in the second reservoir while subjecting the second reservoir to a second elevated temperature by the heating unit for a second predetermined duration of time, to thereby obtain a modified nucleic acid;

g. binding the modified nucleic acid with a second plurality of magnetic beads;

h. while holding the magnetic beads down by elevating the magnet relative to the second plurality of magnetic beads, removing liquid supernatant formed;

j. eluting the bound modified nucleic acid from the second plurality of magnetic beads using a second elution buffer or a second series of elution buffers to thereby obtain a purified modified nucleic acid eluent.

2. The method of claim 1 , wherein said conversion is methylation.

3. The method of claim 2 , wherein the methylation comprises bisulfite conversion.

4. The method of claim 3 , wherein the bisulfite conversion is a deamination of cytosine into uracil of said isolated nucleic acid.

5. The method of claim 3 , wherein the conversion reagent comprises bisulfite.

6. The method of claim 3 , further comprising a step of desulfonation.

7. The method of claim 1 , wherein the sample is selected from the group consisting of whole blood, plasma, serum, buffy coat, saliva, cheek swab, sputum, stool, urine, cerebral spinal fluid, a cell, a tissue and a formalin fixed paraffin embedded (FFPE) sample.

8. The method of claim 1 , wherein the nucleic acid is DNA, RNA, cDNA or a combination thereof.

Assignments (2)
SECURITY INTEREST Recorded Apr 30, 2025
From: SYSTEM BIOSCIENCES, LLC; BIOCHAIN INSTITUTE, INC.
To: TREE LINE CAPITAL AGENT, LLC
Reel/Frame 070982/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2021
From: HAN, XIAOLIANG; WANG, JAMES JIANMING; LU, TONG
To: BIOCHAIN INSTITUTE, INC.
Reel/Frame 056448/0404 →
Continuity (3)
Continuation 15432861 · Feb 14, 2017
Continuation In Part 14517759 · Oct 17, 2014
Related Publication 20200115701A1 · Apr 16, 2020